Delivery Order SPE2DB24D3015-SPE2DB24FFXTV
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$51K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $8,070.20, has an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract without any set-aside designation. The contract is part of the company's broader federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract is a delivery order with a firm fixed price of $1,161.08 and a completion date of June 27, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $11,442.76 with a period of performance through July 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical product to the Defense Logistics Agency (DLA). The contract, valued at $2,757.27, is a Firm Fixed Price Delivery Order with a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,218.43 firm fixed-price delivery order is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as other Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $11,608.10. It was issued by the Defense Logistics Agency (DLA) for the procurement of the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The award, valued at $26,313.77, is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through September 17, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds several Indefinite Delivery...
This federal contract award is for the pharmaceutical product OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,045.49 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML prescription medication. The $12,448.12 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities from AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,102.14 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The contract is a firm fixed-price agreement with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...